The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study.

S, Siracká; LD, Tinková; L, Hochmuth; H, Leščišinová; M, Hrubiško; K, Dostálová; M, Jeseňák

doi:10.5114/ada.2022.116532

Public

The "real-world" effectiveness and safety of omalizumab in patients with uncontrolled persistent allergic asthma in Slovakia: a subgroup analysis of the eXpeRience study.

Shared by NobleBlocks on Jun 1, 2022 • 12:00 AM UTC

Authors:

Siracká S

Tinková LD

Hochmuth L

Abstract

Introduction Omalizumab was proven to be effective and safe in patients with moderate-to-severe allergic asthma. However, there is no direct evidence of the benefits of add-on omalizumab in real-life practice in the Slovakian population.Aim This subgroup analysis assessed the real-life effectiveness...

Subject

Lung function

Omalizumab

Severe Allergic Asthma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!